Clinical Trial Update: Nitazoxanide as Adjuvant Therapy in Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring nitazoxanide as adjuvant therapy in type 2 diabetes mellitus; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Tanta University | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: UNKNOWN